Δευτέρα 16 Μαΐου 2016

A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer

Condition:   Gastro-Oesophageal Cancer
Interventions:   Drug: Regorafenib;   Other: Placebo
Sponsors:   Australasian Gastro-Intestinal Trials Group;   Canadian Cancer Trials Group
Not yet recruiting - verified May 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/255D7PP
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου